Cognition's $1B at $26B: Devin and the 13x Revenue Sprint
Cognition’s May 2026 Series D: over $1B at $26B after 13x run-rate growth to $492M. Superseded for latest print: September 8 Series E closed at more than $2B / $48B — see the Series E memo.
Venture Capital Market Analysis & Investment Trends
Understanding venture capital market dynamics helps founders time their raises and helps investors spot durable themes. Our market analysis covers deal flow, sector concentration, valuation benchmarks, and geographic shifts across the global startup ecosystem.
What Our Market Analysis Covers
- Deal volume & sizing: Round counts, median check sizes, and mega-round activity
- Sector allocation: Where capital is flowing — and where it's pulling back
- Valuation trends: Reset dynamics, revenue multiples, and late-stage pricing
- Regional comparisons: NYC vs. SF, Europe, Asia, and emerging hubs
Browse market analysis articles for data-driven insight into venture capital trends.
Related Articles (355 articles)
-
-
May 2026 Stablecoin VC Surge: Checker, Fasset, Catena — Banks Finally Buy the Rails
Three May deals show stablecoin capital splitting between EM neobanks, FI orchestration APIs, and AI-native banks — infrastructure, not speculation.
-
May 2026's AI Second Layer: Modal, Exa, Decart, and Why the Smart Money Left Chatbots
May funding shows capital stacking on AI infra — serverless GPU, retrieval search, world models, and enterprise delivery — not another wrapper.
-
May 2026 Fintech Infrastructure Wave: Mercury, Primer, Sardine, and the End of 'Neobank Only'
One week in May 2026 saw $400M+ in fintech infra deals — banking, payments AI, fraud, stablecoins, and compliance ops, not consumer apps.
-
Week of May 18–23, 2026: $2.5B+ in Startup Funding — Modal, Decart, Hark Lead
AlleyWatch tracked 34 deals and $2.53B for the week ending May 23 — from Modal's $355M to Hark's $700M Series A, here's what mattered.
-
MiRus's $1.5B: A Medtech Megaround in an AI-Dominated Market
MiRus raised $1.5B in May 2026, one of the month's largest non-AI rounds, underscoring that medical devices can still command megaround capital.